SUMMAR Y To investigate the pathophysiology of narcoleptic patients' sleep in detail, we analysed and compared the whole-night polysomnograms of narcoleptic patients and normal human subjects. Eight drug-naive narcoleptic patients and eight age-matched normal volunteers underwent polysomnography (PSG) on two consecutive nights. In addition to conventional visual scoring of the polysomnograms, rapid eye movement (REM)-density and electroencephalograph (EEG) power spectra analyses were also performed. Sleep onset REM periods and fragmented nocturnal sleep were observed as expected in our narcoleptic patients. In the narcoleptic patients, REM period duration across the night did not show the significant increasing trend that is usually observed in normal subjects. In all narcoleptic patient REM periods, eye movement densities were significantly increased. The power spectra of narcoleptic REM sleep significantly increased between 0.3 and 0.9 Hz and decreased between 1.0 and 5.4 Hz. Further analysis revealed that non-rapid eye movement (NREM) period duration and the declining trend of delta power density in the narcoleptic patients were not significantly different from the normal subjects. Compared with normal subjects, the power spectra of narcoleptic NREM sleep increased in the 1.0-1.4 Hz and 11.0-11.9 Hz frequency bands, and decreased in a 24.0-26.9 Hz frequency band. Thus, increased EEG delta and decreased beta power densities were commonly observed in both the NREM and REM sleep of the narcoleptic patients, although the decrease in beta power during REM sleep was not statistically significant. Our visual analysis revealed fragmented nocturnal sleep and increased phasic REM components in the narcoleptic patients, which suggest the disturbance of sleep maintenance mechanism(s) and excessive effects of the mechanism(s) underlying eye movement activities during REM sleep in narcolepsy. Spectral analysis revealed significant increases in delta components and decreases in beta components, which suggest decreased activity in central arousal mechanisms. These characteristics lead us to hypothesize that two countervailing mechanisms underlie narcoleptic sleep pathology.
INTRODUCTION
Narcolepsy is a chronic sleep disorder characterized by complaints of recurrent excessive daytime sleepiness and cataplexy. Other important features of narcolepsy include sleep paralysis, hypnagogic hallucinations and disrupted nocturnal sleep. Thus, narcoleptic sleep is characterized by overwhelming excessive sleepiness occuring during the daytime, and fragmented nocturnal sleep that is disrupted by numerous awakenings. Polygraphic studies of narcoleptic patients have revealed the frequent presence of sleep-onset rapid eye movement periods (SOREMPs), increased numbers of awakenings and amounts of stage 1 non-rapid eye movement (NREM) sleep, and decreased sleep efficiency, but without substantial changes in total sleep time or total rapid eye movement (REM) sleep (Broughton and Mamelak 1980; Broughton et al. 1988; Browman et al. 1986; Hishikawa et al. 1976; Montplaisir et al. 1978; Montplaisir and Godbout 1986; Nobili et al. 1995; Rechtschaffen et al. 1963; Takahashi 1971; Zorick et al. 1986 ).
More recently, computer analyses of the human sleep electroencephalogram (EEG) have described more detailed changes within EEG frequency bands, including those that underlie visual sleep-stage analysis. Tafti et al. (1992) analysed eight narcoleptic patients and eight normal subjects before and after 24 h of sleep deprivation. They found that slow wave activity (SWA ¼ 0.75-4.5 Hz power) decayed exponentially during both baseline and recovery sleep periods. However, delta and sigma power in NREM, and delta and beta power in REM were significantly greater in the narcoleptic patients compared with normal subjects. Tafti et al. (1992) also reported that delta rebound was significantly more prominent in the narcoleptic patients. Nobili et al. (1995) examined nine narcoleptic patients and nine normal subjects during 32 h of bed rest which followed 16 h of sleep deprivation. They found that both groups showed exponential decays in SWA during the first night's sleep during the 32 h of bed rest. However, the narcoleptic patients slept more than normal patients during the daytime, and no exponential decay was apparent in their second night's sleep; by contrast, the normal subjects' SWA again decayed exponentially during the second night. Hadjiyannakis et al. (1997) examined stage 2-to-REM transitions in narcoleptic patients during nocturnal sleep. The same group (Alloway et al. 1999 ) also examined sleep EEG changes during multiple sleep latency tests, and reported frequency component differences in the narcoleptic patients compared with agematched normal subjects.
Of these studies, Tafti et al. (1992) carried out the most detailed analyses. In the present study we replicated the Tafti et al.'s (1992) studies with additional examinations of higher frequency bands and REM characteristics during REM sleep in eight diagnostically confirmed and drug-naive male narcoleptic patients and eight age-matched male controls, to further elucidate the physiological characteristics of nocturnal sleep in narcoleptic patients.
SUBJECTS AND METHODS

Subjects
The clinical criteria used for the diagnosis of narcoleptic patients in this study were: (i) recurrent daytime sleep episodes, which include naps or other lapses into sleep, occurring almost every day over at least 6 months, and (ii) patient complaints of cataplexy, defined as a sudden bilateral loss of skeletal muscle tone, provoked by a strong wave of positive emotion. All narcoleptic patients in the present study satisfied the criteria for narcolepsy in the International Classification of Sleep Disorders (American Sleep Disorders Association, 1990) .
Patients with coexisting psychiatric, neurological or physical disorders known to affect sleep architecture were identified by abnormal findings in the clinical examination, electrocardiogram (ECG), daytime polysomnography (PSG), or routine laboratory blood chemistry were excluded from the study. Those with a family history of psychiatric or neurological disorders were also excluded.
Eight male drug-naive patients (mean age ¼ 25.3 years, range: 22-28 years) diagnosed with narcolepsy, and eight healthy normal male volunteers (mean age ¼ 24.5 years, range: 22-28 years) matched for age and gender were studied. All narcoleptic patients were recruited from the outpatient clinic of Seiwa Hospital, Tokyo Japan (www. seiwa-hp.com).
Seven of the narcoleptic patients experienced sleep paralysis at some time in their lives; five reported the occurrence of hypnagogic hallucinations at least once per month, and six reported they frequently awoke one to three times during the night. Laboratory examination revealed the presence of human leukocyte antigen (HLA) DRB1*1501 ⁄ DQB1*0602 (Hohjoh et al. 2001) in all narcoleptic patients.
Data from normal subjects were obtained from baseline records obtained earlier in other pharmacological sleep studies performed in the same laboratory. All normal subjects were evaluated and determined to be free of any history of psychiatric, neurological, sleep, or medical disorders. Personal interviews confirmed that normal subjects reported normal sleep habits and no difficulty falling or remaining asleep at night, that they typically slept between 6 and 8 h a night, and that they were generally alert during the daytime.
All participants were requested to abstain from any drugs or alcoholic beverages during the 2 weeks preceding testing and through the duration of the study, and also to refrain from caffeine consumption throughout the study.
Experimental procedures
During the day, subjects were prevented from sleeping. Subjects underwent all-night PSG for two consecutive nights. Only data from the second night were analysed in the present study. Subjects went to bed at 23:00 h and slept undisturbed during PSG recording until 07:00 h.
As narcoleptic patients tend to fall asleep during evening hours, careful attention was paid to preventing premature sleep, especially during monotonous periods such as the application of the recording electrodes. Throughout the night, the behaviors of subjects were monitored in darkness using an infrared video camera.
Polysomnographic recordings included six EEG channels (from scalp electrodes located using the International 10-20 system, placed at F3, F4, C3, C4, O1, and O2, all referred to the contralateral mastoid), two electromyogram (EMG) recordings of the submentalis muscle, four electrooculogram (EOG) channels (horizontal and vertical eye movements), two ECG channels, and one respiratory channel (respiratory effort measured by piezo-electric sensor). Signals were conditioned using Synafit 1000 (NEC Corporation, Tokyo, Japan) amplifiers with low cut filter set at 0.3 Hz for EEG, 3.0 Hz for EOG, and 0.03 Hz for EMG recordings, with corresponding highfrequency filters set at 500 Hz. Signals were backed up on an XR-9000 analog data recorder (TEAC Corporation, Tokyo, Japan).
Visual scoring and spectral analysis
Visual scoring and calculation of sleep parameters Visual sleep-stage scoring was performed using modified Rechtschaffen and Kales (1968) criteria on 20-s epochs synchronized with the spectral analysis described below. The latency to REM sleep was defined as the period between sleep onset and the onset of the first stage scored as REM. Therefore, sleep that began with REM sleep was reflected as a 0-min REM latency. The durations of NREM and REM sleep episodes were measured from the beginning of each NREM period (NREMP) or REM period (REMP) to its end, and included any time spent awake or in stage 1 sleep, applying the criteria of Feinberg and Floyd (1979) .
During REM sleep, REMs were scored visually in a semiquantitative manner. Each 4-s interval of each 20-s scoring epoch was evaluated for the presence or absence of REMs, yielding a REM index between 0 and 5 per epoch of REM sleep. The mean REM density was calculated as the sum of REM indices divided by the total number of REM epochs, for each REMP and for each entire night.
Spectral analysis
The C3 EEG channel was digitized at 512 Hz with an antialiasing filter (cut-off frequency 200-256 Hz) and analysed using the Fast Fourier transform (FFT) power spectral analysis (PSA) available in the Pass Plus sleep analysis system (Delta Software, St Louis, MO, USA; www.deltapass.com). Analyses were performed on consecutive 20-s epochs (average of five 4-s FFT epochs). Power spectra were summed in a 0.3-Hz-wide bin for the frequencies from 0.3 to 0.6 Hz, in a 0.4-Hz-wide bin between 0.6 and 1 Hz, in 0.5-Hz-wide bins between 1 and 15 Hz, in 1-Hz-wide bins between 16 and 30 Hz, and in 2-Hz-wide bins between 30 and 50 Hz. Epochs of wake or stage 1, and those containing EMG or other artifacts in the EEG lead were identified visually and excluded from statistical analyses of the spectral power data.
Statistical analyses
Sleep parameters
Statistical evaluation of differences in baseline night sleep parameters between the narcoleptic patients and the normal subjects was performed using the Mann-Whitney U-test.
Across night trends of NREM and REM period durations were normalized before being compared. Then, a simple F-test was performed to compare the relative NREM or REM lengths in corresponding sleep periods.
The REM densities of the narcoleptic patients and the normal subjects were compared within corresponding sleep periods and collapsed across the night (total REM density) using the Mann-Whitney U-test. To examine the across-night trend of REM densities, the REM density in the first REMPs was compared with later REMPs. Student's t-test was used for that post hoc comparison when significance was obtained by analysis of variance (anova).
Power spectral analysis
To standardize absolute power across subjects, relative power was used in the statistical analyses. Relative power was calculated for each subject as the ratio of power in each frequency analysis bin to that subject's total power. Relative power values in corresponding narcoleptic patient and normal subject bins were compared using the Mann-Whitney U-test. A similar comparison of power spectra from the first NREMP-REMP (analysed separately for NREM and REM) with those from all subsequent periods examined the acrossnight trends in power values for the narcoleptic patient and normal groups. For that comparison, anova was first applied and statistical differences were then evaluated by t-tests in post hoc comparisons.
For NREM periods (NREMPs), comparisons of acrossnight trends of relative power density in the delta band (0.3-3 Hz) were performed within groups by post hoc t-tests after preliminary anova, and between narcoleptic patient and normal groups using repeated-measures anova.
Ethical issues
All experimental procedures and risks were explained prior to recording, and written informed consent was obtained from each patient and subject. This protocol was approved by the Tokyo Institute of Psychiatry Ethics Committee. Table 1 presents sleep architecture variables for the nocturnal sleep of the narcoleptic patients and the normal subjects.
RESULTS
NREM characteristics across sleep periods
Figure 1 presents the durations of the first four consecutive NREMPs for each night and the changes in delta power density across these sleep periods in the narcoleptic patients and the normal subjects. There were no significant differences in NREM duration between groups for corresponding periods. The delta power density of any period was not significantly different between groups (anova: P ¼ 0.068). In the normal subjects, the delta power density showed a declining trend across sleep periods, as the third (post hoc t-test: P ¼ 0.0267) and the fourth period (post hoc t-test: P ¼ 0.0015) were significantly lower than the first NREMP. Figure 2 presents the durations of REMPs and REM densities of the first four REMPs. For the narcoleptic patients, the SOREMP is also shown. In comparison with the REMPs between groups, the first period was longer (F-value ¼ 5.98, P ¼ 0.018) and the fourth period was shorter (F ¼ 7.99, P ¼ 0.007) in the narcoleptic patients.
REM characteristics across sleep periods
Average REM densities of the narcoleptic patients were higher than normal subjects in all REMPs and in total sleep (U-test: P ¼ 0.0087). Significant differences between groups were observed for the first and third periods. In the narcoleptic patients, the changes in REM densities across the night were not significant (anova analysis: F ¼ 0.767, P ¼ 0.554); by contrast, in the normal subjects there were significant acrossnight changes in REM densities (anova analysis: F ¼ 6.110, P ¼ 0.0008), with the second (P ¼ 0.0013) and the fourth (P ¼ 0.0026) REM densities increasing significantly above the first REM density. NREM duration (min) Figure 1 . Across-night trends of non-rapid eye movement period (NREMP) durations and delta power densities. The NREM durations identified by black bars represent the narcoleptic patients, and dotted bars represent the normal subjects. There were no significant differences between narcoleptic patient and normal groups in comparisons of NREM durations (F-test; P < 0.05). Delta power densities (0.3-3 Hz) for the narcoleptic patients are illustrated by thick line; dotted line represents the normal subjects. The marks indicate statistical significance (*P < 0.05, **P < 0.01) within each group (as a proportion of the first NREMP delta power density) compared with the other NREMPs (anova followed by post hoc t-tests). Mann-Whitney U-test *P < 0.01, **P < 0.05.
Results from power spectral analysis
Comparison of NREMP and REMP between narcoleptic patients and normal subjects Figure 3 presents the NREM and REM power spectra of narcoleptic patients relative to normal subjects. Values for each frequency bin represent the power from spectra of the narcoleptic patients divided by that of the normal subjects. Bins that showed statistically significant differences (P < 0.05) are indicated by bars below each graph. During NREM sleep, spectral power in 1-1.4 Hz and 11.0-11.9 Hz frequency bands was significantly greater in the narcoleptic patients, while power in the 24.0-26.9 Hz band was significantly lower in the narcoleptic patients. During REM sleep, spectral power in the narcoleptic patients was significantly enhanced between 0.3 and 0.9 Hz, and significantly reduced in the 1.5-3.4 Hz and 4.0-4.9 Hz frequency bands.
Changes in spectral power across NREM and REM sleep periods
For both groups, the power densities between 0.3 and 39.9 Hz during the second, third and fourth NREMPs and REMPs were evaluated after transformation to ratios of the first NREMP or the first REMP. Figure 4 presents power spectral analyses for NREMPs in each group. In normal subjects (Fig. 4a) , a consistent reduction in 0.6-1.4 Hz power density was observed from the second to the fourth NREMPs (expressed as ratios of the first NREMP) (anova; P < 0.018]. Peaks in the spindle frequency band (12.0-13.9 Hz) emerged in the second, third and fourth NREMPs; relative to the spindle activity during the first NREMP; spindle activity was significantly enhanced in the third and fourth periods. Relative to the power density spectrum of the first NREMP, significant differences were observed in power density of the second NREMP in 8.0-9.9 Hz, and 11.5-13.9 Hz of the third, and in 4. Hz of the fourth NREMP.
The narcoleptic patients (Fig. 4b) exhibited NREM trends similar to those observed for normal subjects, and showed significant increases in the second, third and fourth NREMPs in 23.0-39.9 Hz.
During REM sleep there were no significant differences from the first REMP in the second, third or fourth REMPs of either narcoleptic or normal subjects.
DISC USSION
Using EEG power spectra (from FFT) and visual counts of REM during REM sleep (REM density), as well as conventional visual sleep-stage assessments, we compared drug-naive narcoleptic patients and normal subjects. All results from visual sleep-stage scoring were consistent with past studies.
There were no significant differences between the narcoleptic patients and the normal subjects in either across-night NREM Figure 2 . Across-night trends of rapid eye movement (REM) durations and REM densities. The REM durations for the narcoleptic patients are identified by black bars; dotted bars represent the normal subjects. REM densities for the narcoleptic patients are illustrated by thick line; dotted line represents the normal subjects. The marks indicate statistical significance (*P < 0.05, **P < 0.01) between groups for REM durations (F-test) and within each group for REM densities (anova followed by post hoc t-tests).
period duration changes or the delta power of each NREM period. Sforza et al. (2000) reported a declining trend of 0.75-4.5 Hz activity in idiopathic hypersomnia. In the present study, while the normal subjects showed a significant declining trend in delta power across the night, the decline seen in the narcoleptic patients was not statistically significant. Across the night, the only significant trend in NREM changes seen in the narcoleptic patients was increasing beta frequency power. By contrast, the normal subjects also showed significant trends of increasing power in the theta (4.5-4.9 Hz), alpha (8.0-9.9 Hz) and sigma (15.0-18.9 Hz) bands, and a significant decreasing trend in delta (0.6-1.4 Hz) frequencies. Although an across-night increasing trend in beta activity has been reported (Feinberg et al. 2000; Merica and Blois 1997) , significant increasing trends in normal subjects' theta, alpha, and sigma frequencies have not previously been reported. Because the narcoleptic patients did not show these changes, we speculate that a mildly sleep-disturbing mechanism is active during narcoleptic NREM sleep, obscuring across-night changes. The elevation of narcoleptic patients' 11.0-11.4 Hz frequency power seen in Fig. 3 was an interesting finding, as these frequencies overlap the conventional alpha and slow spindle bands. As indicated in Fig. 4a ,b both normal control and narcoleptic patients showed enhancement of spindle frequency (12-13 Hz) in later NREM periods. However, the frequency which increased significantly in narcoleptic patients, compared with normal patients, was slightly slower than spindle frequency. This could suggest that not only spindle, but also higher alpha band frequencies are enhanced in narcoleptic patients. Although the number of organized sleep spindle bursts was not measured in the present study, our impressions from visual sleep stage scoring suggest there may be increased numbers of sleep spindles in narcoleptic patients. Bove et al. (1994) visually examined spindle density and reported that the density was significantly higher in narcoleptic patients than in normal control subjects. Animal studies have indicated that the physiological mechanism of spindle generation involves the hyperpolarization of thalamic neurons, resulting in the blockade of incoming sensory impulses and functional deafferentation of the cerebral cortex, thus serving to maintain NREM sleep (Steriade et al. 1993) . Increased rates of spindle occurrence in narcoleptic patients could thus be interpreted to reflect a response to an elevated demand for sleep maintenance, which would in turn imply the activity of a sleep-disturbing mechanism. Similarly, increased alpha band activity could also be a result of such a sleep-disturbing mechanism. Thus, the alpha and spindle band characteristics of NREM periods in narcoleptic patients may reflect increased, if latent, awake phases.
By contrast with these NREM differences, the narcoleptic patients and the normal subjects differed much more during REM sleep. While no normal subjects exhibited SOREMPs, all narcoleptic patients did (Rechtschaffen et al. 1963; Takahashi and Jimbo 1963) . Throughout each night, REM densities during REM sleep were significantly greater in the narcoleptic NREM P < 0.05 REM P < 0.05 Figure 3 . The ratios of power spectral densities in non-rapid eye movement (NREM) (thick line) and rapid eye movement (REM) (thin line) sleep, between groups. The ratio was calculated by dividing the power density of the narcoleptic patients by that of the normal subjects. Statistical differences in the power densities in each frequency bin between groups are illustrated below the figure (U-test, P < 0.05).
patients than the normal subjects in every REMP, suggesting the pathological elevations of phasic mechanisms during REM sleep. The present REM density finding is in good agreement with three previous reports (Geisler et al. 1987; Reynolds et al. 1983; Vankova et al. 2001) . Across-night changes in REMP duration also differed significantly between the two groups. Figure 4 . (a) and (b) both show the across-night trends of non-rapid eye movement power spectra in normal subjects and narcoleptic patients. Line styles indicate the ratios of the second (thin line), the third (moderate line) and the fourth (thick line) non-rapid eye movement periods compared with the first in each group. Significant differences (one-way anova, P < 0.05) of every ratio relative to the first are shown below the figure by thick bars.
Narcoleptic patients did not show increasing REMP durations across the night, which was evident and expected in the normal subjects. These results may suggest that a circadian variation of REM propensity (Borbely 1982 ) is mildly disturbed in the narcoleptic patients. Results by Nobili et al. (1995) , which manifested an ultradian rather than circadian trend, also support this hypothesis. The pathophysiology underlying phenomena such as enhanced phasic REM activity could account for ÔREM-relatedÕ narcoleptic patient symptoms such as cataplexy, sleep paralysis and hypnagogic hallucinations. However, it has been reported that cataplexy does not exhibit the ultradian rhythmicity observed in the occurrence of REM sleep (Nishino et al. 2000) , suggesting that an abnormality may be closely related to REM sleep, yet not REM-specific.
In the present study, narcoleptic patients showed common changes in the EEG spectra of both NREM and REM sleep, namely significantly increased delta power density and significantly decreased beta power density. In normal subjects, however, beta band power density increased across the night, and showed an inverse relationship with delta band changes across sleep, as we have reported previously (Uchida et al. 1992) . As delta power density has been considered to reflect sleep intensity (Borbely 2001; Feinberg et al. 1976) , we have hypothesized that beta power density may reflect the level of a central arousal mechanism (Uchida et al. 1992) . A study of the relation of global (gCBF) and regional cerebral blood flow (rCBF) to EEG frequencies in NREM sleep performed by one of the authors (S.U) and others (manuscript submitted) found that beta power was positively correlated with rCBF in regions including the brainstem, pons, midbrain, and thalamus. Thus, the reduction in beta activity in the present study suggests that the central arousal level during NREM sleep may be lower in the narcoleptic patients, perhaps because of an intensified sleep-promoting mechanism. This hypothesis is also consistent with the present finding of slightly elevated delta power obtained in the narcoleptic patients during both NREM and REM. Although the low frequency beta power density during REM did not decrease significantly, the average was lower in the narcoleptic patients, consistent with the hypothesis that central arousal level is generally lower in the narcoleptic patients. However, this finding and interpretation are at odds with Tafti et al.'s (1992) demonstration of elevated beta in narcoleptic subjects' REM. This discrepancy should be examined in future studies.
A strong phasic REM enhancement mechanism and unstable conscious state maintenance, accompanied by generally lower central arousal levels are the essential phenomena of narcolepsy. Presumably, most NREM phenomena in narcolepsy are normal reactions to the essential pathology. Thus, we hypothesize that there are two countervailing mechanisms in narcoleptic pathophysiology. One mechanism results in lowered central arousal, and the other, in disturbed sleep maintenance, which may be related to excessive phasic REM activities. An animal model of narcolepsy has recently elucidated the importance of a genetic abnormality in the orexin ⁄ hypocretin receptor. Although recent human studies suggest that humans do not exhibit the same abnormality, Nishino et al. (2001) have indicated that the orexin ⁄ hypocretin level is very low in the CNS fluid of humans with narcolepsy. Thus, the role of orexin ⁄ hypocretin on the neuro-mechanisms of consciousness regulation may turn out to play an essential role in narcoleptic pathophysiology.
